Johns Hopkins Medicine publiczne
[search 0]
Więcej
Download the App!
show episodes
 
The Center for Nursing Inquiry oversees the scholarly work of nurses in the Johns Hopkins Health System. Our goal is to build the capacity for nurses to participate in the three forms of inquiry: research, evidence-based practice (EBP), and quality improvement (QI). At the Center for Nursing Inquiry, we offer a variety of educational resources and expert guidance to help nurses engage in meaningful, high-quality scholarly work. We are dedicated to advancing the science of nursing. Stay conne ...
  continue reading
 
Loading …
show series
 
Metformin is a older medication used for type 2 diabetes that’s now being evaluated for improving longevity. Another diabetes medicine called a GLP-1 agonist is being used to treat obesity. Diabetes expert Rita Kalyani at Johns Hopkins says possible expanded … Several diabetes medicines are being eyed for use outside of this condition, Elizabeth Tr…
  continue reading
 
Metformin is a older medication used for type 2 diabetes that’s now being evaluated for improving longevity. Another diabetes medicine called a GLP-1 agonist is being used to treat obesity. Diabetes expert Rita Kalyani at Johns Hopkins says possible expanded … Several diabetes medicines are being eyed for use outside of this condition, Elizabeth Tr…
  continue reading
 
Metformin is a older medication used for type 2 diabetes that’s now being evaluated for improving longevity. Another diabetes medicine called a GLP-1 agonist is being used to treat obesity. Diabetes expert Rita Kalyani at Johns Hopkins says possible expanded … Several diabetes medicines are being eyed for use outside of this condition, Elizabeth Tr…
  continue reading
 
Metformin is a older medication used for type 2 diabetes that’s now being evaluated for improving longevity. Another diabetes medicine called a GLP-1 agonist is being used to treat obesity. Diabetes expert Rita Kalyani at Johns Hopkins says possible expanded … Several diabetes medicines are being eyed for use outside of this condition, Elizabeth Tr…
  continue reading
 
Yet another study has come out recommending the class of medicines called GLP-1 agonists for type 2 diabetes. These medicines are already in the news to treat obesity, both in those with diabetes and those without, and more conditions that … Will everyone soon be taking a medicine first developed to manage type 2 diabetes? Elizabeth Tracey reports …
  continue reading
 
Yet another study has come out recommending the class of medicines called GLP-1 agonists for type 2 diabetes. These medicines are already in the news to treat obesity, both in those with diabetes and those without, and more conditions that … Will everyone soon be taking a medicine first developed to manage type 2 diabetes? Elizabeth Tracey reports …
  continue reading
 
Yet another study has come out recommending the class of medicines called GLP-1 agonists for type 2 diabetes. These medicines are already in the news to treat obesity, both in those with diabetes and those without, and more conditions that … Will everyone soon be taking a medicine first developed to manage type 2 diabetes? Elizabeth Tracey reports …
  continue reading
 
Yet another study has come out recommending the class of medicines called GLP-1 agonists for type 2 diabetes. These medicines are already in the news to treat obesity, both in those with diabetes and those without, and more conditions that … Will everyone soon be taking a medicine first developed to manage type 2 diabetes? Elizabeth Tracey reports …
  continue reading
 
Diabetes medicine known as GLP-1 agonists and SGLT-2 inhibitors are recommended for people with type 2 diabetes in a recent large study that aggregated data from other studies. Rita Kalyani, a diabetes expert at Johns Hopkins, says while there’s no … Are certain diabetes medicines best for specific people? Elizabeth Tracey reports Read More »…
  continue reading
 
Diabetes medicine known as GLP-1 agonists and SGLT-2 inhibitors are recommended for people with type 2 diabetes in a recent large study that aggregated data from other studies. Rita Kalyani, a diabetes expert at Johns Hopkins, says while there’s no … Are certain diabetes medicines best for specific people? Elizabeth Tracey reports Read More »…
  continue reading
 
Diabetes medicine known as GLP-1 agonists and SGLT-2 inhibitors are recommended for people with type 2 diabetes in a recent large study that aggregated data from other studies. Rita Kalyani, a diabetes expert at Johns Hopkins, says while there’s no … Are certain diabetes medicines best for specific people? Elizabeth Tracey reports Read More »…
  continue reading
 
Diabetes medicine known as GLP-1 agonists and SGLT-2 inhibitors are recommended for people with type 2 diabetes in a recent large study that aggregated data from other studies. Rita Kalyani, a diabetes expert at Johns Hopkins, says while there’s no … Are certain diabetes medicines best for specific people? Elizabeth Tracey reports Read More »…
  continue reading
 
Let’s say you’ve just been diagnosed with type 2 diabetes, but outside of that condition you have no other health issues. Should you take a newer class of diabetes medicine or will one of the older ones serve you just … When are newer diabetes medicines best? Elizabeth Tracey reports Read More »Autor: Johns Hopkins Medicine
  continue reading
 
Let’s say you’ve just been diagnosed with type 2 diabetes, but outside of that condition you have no other health issues. Should you take a newer class of diabetes medicine or will one of the older ones serve you just … When are newer diabetes medicines best? Elizabeth Tracey reports Read More »Autor: Johns Hopkins Medicine
  continue reading
 
Let’s say you’ve just been diagnosed with type 2 diabetes, but outside of that condition you have no other health issues. Should you take a newer class of diabetes medicine or will one of the older ones serve you just … When are newer diabetes medicines best? Elizabeth Tracey reports Read More »Autor: Johns Hopkins Medicine
  continue reading
 
Let’s say you’ve just been diagnosed with type 2 diabetes, but outside of that condition you have no other health issues. Should you take a newer class of diabetes medicine or will one of the older ones serve you just … When are newer diabetes medicines best? Elizabeth Tracey reports Read More »Autor: Johns Hopkins Medicine
  continue reading
 
If you have type 2 diabetes, what are the best medicines to manage it? A new meta-analysis looks at aggregated data from a number of studies and comes out in favor of the newer classes of drugs. Rita Kalyani, a … What are the best medicines to manage diabetes? Elizabeth Tracey reports Read More »Autor: Johns Hopkins Medicine
  continue reading
 
If you have type 2 diabetes, what are the best medicines to manage it? A new meta-analysis looks at aggregated data from a number of studies and comes out in favor of the newer classes of drugs. Rita Kalyani, a … What are the best medicines to manage diabetes? Elizabeth Tracey reports Read More »Autor: Johns Hopkins Medicine
  continue reading
 
If you have type 2 diabetes, what are the best medicines to manage it? A new meta-analysis looks at aggregated data from a number of studies and comes out in favor of the newer classes of drugs. Rita Kalyani, a … What are the best medicines to manage diabetes? Elizabeth Tracey reports Read More »Autor: Johns Hopkins Medicine
  continue reading
 
If you have type 2 diabetes, what are the best medicines to manage it? A new meta-analysis looks at aggregated data from a number of studies and comes out in favor of the newer classes of drugs. Rita Kalyani, a … What are the best medicines to manage diabetes? Elizabeth Tracey reports Read More »Autor: Johns Hopkins Medicine
  continue reading
 
Cancer of the esophagus can be challenging to treat, and when it’s diagnosed a number of studies are appropriate to fully evaluate the disease. That’s according to Richard Battafarano, director of thoracic surgery at Johns Hopkins. Battafarano: Undergoing endoscopic ultrasound … A range of tests should accompany evaluation for esophagus cancer, Eli…
  continue reading
 
Cancer of the esophagus can be challenging to treat, and when it’s diagnosed a number of studies are appropriate to fully evaluate the disease. That’s according to Richard Battafarano, director of thoracic surgery at Johns Hopkins. Battafarano: Undergoing endoscopic ultrasound … A range of tests should accompany evaluation for esophagus cancer, Eli…
  continue reading
 
Cancer of the esophagus can be challenging to treat, and when it’s diagnosed a number of studies are appropriate to fully evaluate the disease. That’s according to Richard Battafarano, director of thoracic surgery at Johns Hopkins. Battafarano: Undergoing endoscopic ultrasound … A range of tests should accompany evaluation for esophagus cancer, Eli…
  continue reading
 
Cancer of the esophagus can be challenging to treat, and when it’s diagnosed a number of studies are appropriate to fully evaluate the disease. That’s according to Richard Battafarano, director of thoracic surgery at Johns Hopkins. Battafarano: Undergoing endoscopic ultrasound … A range of tests should accompany evaluation for esophagus cancer, Eli…
  continue reading
 
Esophagus cancer awareness month has just ended, and Richard Battafarano, director of thoracic surgery at Johns Hopkins, says while some people may have this type of cancer and not know it, the majority will have a range of symptoms. Battafarano: … What are the symptoms of cancer of the esophagus? Elizabeth Tracey reports Read More »…
  continue reading
 
Esophagus cancer awareness month has just ended, and Richard Battafarano, director of thoracic surgery at Johns Hopkins, says while some people may have this type of cancer and not know it, the majority will have a range of symptoms. Battafarano: … What are the symptoms of cancer of the esophagus? Elizabeth Tracey reports Read More »…
  continue reading
 
Esophagus cancer awareness month has just ended, and Richard Battafarano, director of thoracic surgery at Johns Hopkins, says while some people may have this type of cancer and not know it, the majority will have a range of symptoms. Battafarano: … What are the symptoms of cancer of the esophagus? Elizabeth Tracey reports Read More »…
  continue reading
 
Esophagus cancer awareness month has just ended, and Richard Battafarano, director of thoracic surgery at Johns Hopkins, says while some people may have this type of cancer and not know it, the majority will have a range of symptoms. Battafarano: … What are the symptoms of cancer of the esophagus? Elizabeth Tracey reports Read More »…
  continue reading
 
Bladder cancer treatment is about to change dramatically based on a trial showing that adding an antibody to a toxic substance is much more effective than current treatments. Johns Hopkins Kimmel Cancer director William Nelson describes this class of pharmaceuticals. … A new type of pharmaceutical to treat bladder cancer may become the method of ch…
  continue reading
 
Bladder cancer treatment is about to change dramatically based on a trial showing that adding an antibody to a toxic substance is much more effective than current treatments. Johns Hopkins Kimmel Cancer director William Nelson describes this class of pharmaceuticals. … A new type of pharmaceutical to treat bladder cancer may become the method of ch…
  continue reading
 
Bladder cancer treatment is about to change dramatically based on a trial showing that adding an antibody to a toxic substance is much more effective than current treatments. Johns Hopkins Kimmel Cancer director William Nelson describes this class of pharmaceuticals. … A new type of pharmaceutical to treat bladder cancer may become the method of ch…
  continue reading
 
Bladder cancer treatment is about to change dramatically based on a trial showing that adding an antibody to a toxic substance is much more effective than current treatments. Johns Hopkins Kimmel Cancer director William Nelson describes this class of pharmaceuticals. … A new type of pharmaceutical to treat bladder cancer may become the method of ch…
  continue reading
 
Stool based tests to screen for colorectal cancer have been around for some time and work pretty well. Now one of the most utilized ones has been improved, a clinical trial shows. William Nelson, director of the Kimmel Cancer Center … A stool based test for colorectal cancer just got an update, Elizabeth Tracey reports Read More »…
  continue reading
 
Stool based tests to screen for colorectal cancer have been around for some time and work pretty well. Now one of the most utilized ones has been improved, a clinical trial shows. William Nelson, director of the Kimmel Cancer Center … A stool based test for colorectal cancer just got an update, Elizabeth Tracey reports Read More »…
  continue reading
 
Loading …

Skrócona instrukcja obsługi